D. Prieto-Alhambra

First name
D.
Last name
Prieto-Alhambra
Barclay, N. L., Català, M., Jödicke, A. M., Prieto-Alhambra, D., Newby, D., Delmestri, A., et al. (2024). Collateral effects of the COVID-19 pandemic on endocrine treatments for breast and prostate cancer in the UK: a cohort study. Ther Adv Med Oncol, 16, 17588359241253115. http://doi.org/10.1177/17588359241253115
View
Reyes, C., Newby, D., Raventós, B., Verhamme, K., Mosseveld, M., Prieto-Alhambra, D., et al. (2024). Trends of use and characterisation of anti-dementia drugs users: a large multinational-network population-based study. Age Ageing, 53. http://doi.org/10.1093/ageing/afae106
View
Tan, E. H., Rathod-Mistry, T., . Y. Strauss, V., O'Kelly, J., Giorgianni, F., Baxter, R., et al. (2024). Evaluating the comparability of osteoporosis treatments using propensity score and negative control outcome methods in UK and Denmark electronic health record databases. J Bone Miner Res. http://doi.org/10.1093/jbmr/zjae059
View
Català, M., Mercadé-Besora, N., Kolde, R., Trinh, N. T. H., Roel, E., Burn, E., et al. (2024). The effectiveness of COVID-19 vaccines to prevent long COVID symptoms: staggered cohort study of data from the UK, Spain, and Estonia. Lancet Respir Med, 12, 225-236. http://doi.org/10.1016/s2213-2600(23)00414-9
View
Català, M., Mercadé-Besora, N., Kolde, R., Trinh, N. T. H., Roel, E., Burn, E., et al. (2024). The effectiveness of COVID-19 vaccines to prevent long COVID symptoms: staggered cohort study of data from the UK, Spain, and Estonia. Lancet Respir Med. http://doi.org/10.1016/s2213-2600(23)00414-9
View
Jödicke, A. M., Tan, E. H., Robinson, D. E., Delmestri, A., & Prieto-Alhambra, D. (2023). Risk of adverse events following the initiation of antihypertensives in older people with complex health needs: a self-controlled case series in the United Kingdom. Age Ageing, 52. http://doi.org/10.1093/ageing/afad177
View
Català, M., Burn, E., Rathod-Mistry, T., Xie, J., Delmestri, A., Prieto-Alhambra, D., & Jödicke, A. M. (2023). Observational methods for COVID-19 vaccine effectiveness research: an empirical evaluation and target trial emulation. Int J Epidemiol. http://doi.org/10.1093/ije/dyad138
View
Matthewman, J., Tadrous, M., Mansfield, K. E., Thiruchelvam, D., Redelmeier, D. A., Cheung, A. M., et al. (2023). Association of Different Prescribing Patterns for Oral Corticosteroids With Fracture Preventive Care Among Older Adults in the UK and Ontario. Jama Dermatol. http://doi.org/10.1001/jamadermatol.2023.2495
View
Tan, E. H., Robinson, D. E., Jödicke, A. M., Mosseveld, M., Bødkergaard, K., Reyes, C., et al. (2023). Drug utilization analysis of osteoporosis medications in seven European electronic health databases. Osteoporos Int. http://doi.org/10.1007/s00198-023-06837-0
View
Voss, E. A., Shoaibi, A., Lai, Y. H., Blacketer, C., Alshammari, T., Makadia, R., et al. (2023). Contextualising adverse events of special interest to characterise the baseline incidence rates in 24 million patients with COVID-19 across 26 databases: a multinational retrospective cohort study. Eclinicalmedicine, 58, 101932. http://doi.org/10.1016/j.eclinm.2023.101932
View